Exhibit 107

 

Calculation of Filing Fee Tables

 

Form S-3

 

(Form Type)

 

Lantern Pharma Inc.

 

(Exact Name of Registrant as Specified in its Charter)

 

Table 1: Newly Registered and Carry Forward Securities

 


   Security Type  Security Class Title  Fee Calculation or Carry Forward Rule   Amount Registered (a) 

Proposed Maximum Offering Price Per

Unit

  Maximum Aggregate Offering Price Fee Rate  Amount of Registration Fee   Carry Forward Form Type  Carry Forward File Number 

Carry Forward Initial effective

date

  Filing Fee Previously Paid In Connection with Unsold Securities to be Carried Forward
Newly Registered Securities
Fees to Be Paid  Equity  Common stock, $0.001 par value                                      
   Debt  Debt Securities                                      
   Other  Warrants                                    
   Other  Units                                    
   Other  Subscription Rights                                    
   Unallocated (Universal) Shelf      Rule 457(o)   (b)  (b)  $150,000,000(c) $147.60 per $1,000,000  $22,140.00               
Fees Previously Paid                                            
Carry Forward Securities
Carry Forward Securities Unallocated (Universal) Shelf  Unallocated (Universal) Shelf   415(a)(6)         $150,000,000   $109.10 per $1,000,000  $16,365.00   S-3  333-257643  07/02/2021  $ 16,365.00
   Total Offering Amounts      $22,140.00             
   Total Fees Previously Paid       -0-               
   Total Fee Offsets      $16,365.00             
   Net Fee Due      $5,775.00               

 

(a) In accordance with Rule 416 under the Securities Act of 1933, as amended (the “Securities Act”), this registration statement shall be deemed to cover an indeterminate number of additional shares of Common Stock to be offered or issued from stock splits, stock dividends or similar transactions.

 

(b) Pursuant to Instruction 2.A.iii.b. of Item 16(b) of Form S-3, this information is not specified as to each class of securities to be registered. There is being registered hereby such indeterminate number of the securities of each identified class as may from time to time be issued at indeterminate prices. Securities registered hereunder may be sold separately, together or in units with other securities registered hereunder

 

(c) The proposed maximum aggregate offering price has been estimated solely to calculate the registration fee in accordance with Rule 457(o) under the Securities Act.

 

(d) An aggregate of $16,365.00 of the amount of the registration fee was previously paid in connection with the unissued securities registered under the Registrant’s registration statement on Form S-3 (File No. 333-257643) initially filed on July 2, 2021, or the Prior Registration Statement. No securities were sold under the Prior Registration Statement. The Registrant is allowed to apply $16,365 toward the registration fee for this registration statement in reliance on Rule 415(a)(6), because $150,000,000 of unsold securities (and associated fees) are being moved from the Prior Registration Statement to this registration statement. Pursuant to Rule 415(a)(6), the $16,365.00 registration fee previously paid by the Registrant relating to the unsold securities included on this registration statement will continue to be applied to such unsold securities.

 

 
 

 

Table 2: Fee Offset Claims and Sources

 

   Registrant or Filer Name   Form or Filing Type   File Number   Initial Filing Date   Filing Date   Fee Offset Claimed   Security Type Associated with Fee Offset Claimed  Security Title Associated with Fee Offset Claimed  Unsold Securities Associated with Fee Offset Claimed  Unsold Aggregate Offering Amount Associated with Fee Offset Claimed   Fee Paid with Fee Offset Source 

Rules 457(b) and 0-11(a)(2)

Fee Offset Claims                                                
Fee Offset Sources                                                

Rule 457(p)

Fee Offset Claims   Lantern Pharma Inc.    S-3    333-257643    07/02/2021        $16,365.00   Unallocated (Universal) Shelf  Unallocated (Universal) Shelf  Unallocated (Universal) Shelf  $150,00,000      
Fee Offset Sources   Lantern Pharma Inc.    S-3    333-257643    07/02/2021                           $16,365.00(a)

 

  (a) An aggregate of $16,365.00 of the amount of the registration fee was previously paid in connection with $150,000,000 of unissued securities registered under the Registrant’s registration statement on Form S-3 (File No. 333-257643) initially filed on July 2, 2021, or the Prior Registration Statement. The Registrant is allowed to apply $16,365.00 toward the registration fee for this registration statement in reliance on Rule 415(a)(6), because the $150,000,000 of unsold securities (and associated fees) are being moved from the Prior Registration Statement to this registration statement. Pursuant to Rule 415(a)(6), the $16,365.00 registration fee previously paid by the Registrant relating to the unsold securities included on this registration statement will continue to be applied to such unsold securities.